Hodgson A - Search Results

1

Evaluation of cancer testis antigen (CT10, PRAME) and MHC I expression in high-grade urothelial carcinoma of the bladder.

Hodgson A, Jungbluth AA, Katabi N, Xu B, Downes MR. Hodgson A, et al. Virchows Arch. 2020 Apr;476(4):535-542. doi: 10.1007/s00428-019-02661-2. Epub 2019 Sep 2. Virchows Arch. 2020. PMID: 31485721 Free PMC article.

2

p53 immunohistochemistry in high-grade urothelial carcinoma of the bladder is prognostically significant.

Hodgson A, Xu B, Downes MR. Hodgson A, et al. Histopathology. 2017 Aug;71(2):296-304. doi: 10.1111/his.13225. Epub 2017 May 22. Histopathology. 2017. PMID: 28342221

3

Tumour front inflammation and necrosis are independent prognostic predictors in high-grade urothelial carcinoma of the bladder.

Hodgson A, Xu B, Satkunasivam R, Downes MR. Hodgson A, et al. J Clin Pathol. 2018 Feb;71(2):154-160. doi: 10.1136/jclinpath-2017-204562. Epub 2017 Aug 2. J Clin Pathol. 2018. PMID: 28768702

4

PD-L1 Immunohistochemistry Assay Concordance in Urothelial Carcinoma of the Bladder and Hypopharyngeal Squamous Cell Carcinoma.

Hodgson A, Slodkowska E, Jungbluth A, Liu SK, Vesprini D, Enepekides D, Higgins K, Katabi N, Xu B, Downes MR. Hodgson A, et al. Am J Surg Pathol. 2018 Aug;42(8):1059-1066. doi: 10.1097/PAS.0000000000001084. Am J Surg Pathol. 2018. PMID: 29750666 Free PMC article.

5

International Endocervical Adenocarcinoma Criteria and Classification: Validation and Interobserver Reproducibility.

Hodgson A, Park KJ, Djordjevic B, Howitt BE, Nucci MR, Oliva E, Stolnicu S, Xu B, Soslow RA, Parra-Herran C. Hodgson A, et al. Am J Surg Pathol. 2019 Jan;43(1):75-83. doi: 10.1097/PAS.0000000000001095. Am J Surg Pathol. 2019. PMID: 29877920 Free PMC article.

6

Basal-subtype bladder tumours show a 'hot' immunophenotype.

Hodgson A, Liu SK, Vesprini D, Xu B, Downes MR. Hodgson A, et al. Histopathology. 2018 Nov;73(5):748-757. doi: 10.1111/his.13696. Epub 2018 Aug 14. Histopathology. 2018. PMID: 29947424

7

Correlation of mismatch repair protein deficiency, PD-L1 and CD8 expression in high-grade urothelial carcinoma of the bladder.

Hodgson A, Vesprini D, Liu SK, Xu B, Downes MR. Hodgson A, et al. J Clin Pathol. 2020 Aug;73(8):519-522. doi: 10.1136/jclinpath-2019-206256. Epub 2020 Jan 9. J Clin Pathol. 2020. PMID: 31919144

8

A Practical Approach to Investigating Cross-Contaminants in the Anatomical Pathology Laboratory.

Hodgson AJ, Shang YM, Boulianne P, Downes MR, Hwang D, Slodkowska E. Hodgson AJ, et al. Int J Surg Pathol. 2020 Oct;28(7):700-710. doi: 10.1177/1066896920913110. Epub 2020 Mar 18. Int J Surg Pathol. 2020. PMID: 32188330

9

Immune gene expression profiles in high-grade urothelial carcinoma of the bladder: a NanoString study.

Olkhov-Mitsel E, Hodgson A, Liu SK, Vesprini D, Bayani J, Bartlett J, Xu B, Downes MR. Olkhov-Mitsel E, et al. Among authors: hodgson a. J Clin Pathol. 2021 Jan;74(1):53-57. doi: 10.1136/jclinpath-2020-206631. Epub 2020 May 29. J Clin Pathol. 2021. PMID: 32471889

10

Reassessment of p53 immunohistochemistry thresholds in invasive high grade bladder cancer shows a better correlation with TP53 and FGFR3 mutations.

Hodgson A, van Rhijn BWG, Kim SS, Ding C, Saleeb R, Vesprini D, Liu SK, Yousef GM, van der Kwast TH, Xu B, Downes MR. Hodgson A, et al. Pathol Res Pract. 2020 Nov;216(11):153186. doi: 10.1016/j.prp.2020.153186. Epub 2020 Aug 23. Pathol Res Pract. 2020. PMID: 32861170

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

642 results

Search Page

Filters